After left nephrectomy and adrenalectomy for a renal mass without known pheochromocytoma, should I be concerned about postoperative catecholamine excess from the removed adrenal gland?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Postoperative Catecholamine Excess After Adrenalectomy Without Known Pheochromocytoma

Direct Answer

No, you do not need to worry about postoperative catecholamine excess from the excised adrenal gland in a patient who underwent nephrectomy and adrenalectomy for a renal mass without known pheochromocytoma. The primary concern after removing a catecholamine-secreting tumor is the opposite problem—profound hypotension from sudden catecholamine withdrawal, not continued excess from the removed tissue 1.

Why Catecholamine Excess Is Not a Concern

Once the adrenal gland is removed, catecholamine production ceases immediately. The excised tissue cannot continue to secrete catecholamines into the patient's circulation 2. Research demonstrates that catecholamine release occurs during surgical manipulation of pheochromocytomas (pneumoperitoneum creation and tumor handling), but this resolves immediately after tumor removal 2.

  • Plasma and urine catecholamine levels return to normal or subnormal values after adrenalectomy for pheochromocytoma 3
  • The hemodynamic instability that occurs postoperatively is hypotension requiring vasopressor support (47% of patients), not hypertension from excess catecholamines 4

The Actual Postoperative Concerns

Hypotension and Hemodynamic Instability

The real risk is profound hypotension due to sudden catecholamine withdrawal and pre-existing peripheral hypovolemia after tumor removal 1, 5. This occurs in approximately 47% of patients undergoing adrenalectomy for pheochromocytoma, with 29% requiring vasopressor therapy 4.

  • Aggressive fluid resuscitation is essential to treat the sudden blood pressure drops that commonly occur 5
  • Intensive care monitoring for at least 24-48 hours is recommended for aggressive hemodynamic management 5

Adrenal Insufficiency

If the patient had any degree of cortisol-secreting function or if bilateral adrenal tissue was affected, adrenal crisis is a critical concern 1, 5.

  • Hydrocortisone 150 mg/day should be administered during surgery and postoperatively if there was any glucocorticoid excess or risk of adrenal insufficiency 1
  • Transition to maintenance therapy with oral hydrocortisone 15-25 mg/day in divided doses after the acute period 5
  • Add fludrocortisone 0.05-0.2 mg daily for mineralocorticoid replacement if needed 5

Hypoglycemia

Monitor blood glucose closely as hypoglycemia commonly occurs after sudden reduction in catecholamine levels 5.

  • Check glucose every 2-4 hours initially, as catecholamines normally antagonize insulin and promote gluconeogenesis 5

Critical Context: Was This Actually a Pheochromocytoma?

The key question is whether preoperative biochemical screening was performed to exclude pheochromocytoma before surgery 6.

  • All patients with adrenal masses should be screened for pheochromocytoma with plasma or 24-hour urinary metanephrines before any surgical intervention 6
  • Never perform adrenal biopsy or surgery without excluding pheochromocytoma first, as this can trigger life-threatening hypertensive crisis 6

If no preoperative screening was done and the patient had an unrecognized pheochromocytoma:

  • The intraoperative period would have shown significant catecholamine release during tumor manipulation, requiring aggressive blood pressure control 2
  • Postoperatively, the concern remains hypotension, not hypertension 4
  • Measure plasma or urine metanephrines at 2-8 weeks postoperatively to confirm there was no residual catecholamine-secreting tissue 5

Monitoring Recommendations

For this specific case (nephrectomy + adrenalectomy for renal mass without known pheochromocytoma):

  • Monitor for hypotension and hemodynamic instability in the immediate postoperative period 5, 4
  • Check blood glucose frequently to detect hypoglycemia 5
  • Consider measuring plasma metanephrines at 2-8 weeks postoperatively if there is any clinical suspicion that an unrecognized pheochromocytoma was present 5
  • Assess for signs of adrenal insufficiency (severe hypotension, nausea, vomiting, abdominal pain, altered mental status) and treat immediately with IV hydrocortisone 100 mg if suspected 5

Common Pitfall to Avoid

Do not confuse intraoperative catecholamine release (which occurs during tumor manipulation) with postoperative catecholamine excess from the excised tissue 2. The former is a real phenomenon requiring aggressive blood pressure control during surgery, but once the tumor is removed, catecholamine production stops immediately 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Bilateral pheochromocytoma. Is there stimulation of an extra-adrenal adrenaline liberation after bilateral adrenalectomy?].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1992

Guideline

Postoperative Management of Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pheochromocytoma Screening Before Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.